SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Roselabs Group's Firms invests over Rs 400 crore to set up PFS making facility at Ahmedabad

19 Jun 2013 Evaluate

Roselabs Group's Firms, Roselabs Bioscience and Roselabs Polymers have invested over Rs 400 crore to set up 'pre-filled syringes' (PFS) making facility near Ahmedabad with a capacity to manufacture 8 lakh syringes per day. The company’s facility near Ahmedabad has capabilities to make both glass and polymer (Cyclic Olefin Copolymer) syringes.

The two companies, which target Rs 100 crore turnover by this fiscal year end, so far, have commercialized 26 products in the PFS segment in India.

Roselab Biosciences, which manufactures glass pre-filled syringes, pre-fillable syringes, formulations and cytotoxic Active Pharmaceutical Ingredients (API) and Roselab Polymers, which delivers sterile, clean and ready to fill pre-fillable polymer syringes, are the group companies of Roselabs.

Peers
Company Name CMP
Redington 280.90
Amrapali Industries 42.31
Adani Enterprises 3037.90
Rashi Peripheral 752.80
PDS 338.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: